We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Balloon Sinuplasty Helps Chronic Sinusitis Patients

By HospiMedica staff writers
Posted on 21 Apr 2008
Balloon sinuplasty technology safely opens narrow sinuses, is economical, and is highly satisfactory to chronic sinusitis patients, according to a new study.

Researchers at the Cleveland Nasal, Sinus and Sleep Center (OH, USA) and other institutions conducted a multicenter registry study of balloon catheter-sinusotomy outcomes for 1036 patients. More...
The data were collected by standardized chart review with centralized database administration for all consecutive functional endoscopic sinus surgeries that included the use of balloon catheters across the 18-month period from December 2005 to May 2007. The study results showed that balloon catheters were used in 3276 peripheral (maxillary, frontal, and sphenoid) sinuses, for an average of 3.2 sinuses per patient. The revision rate was 1.3% of sinuses treated with a balloon catheter after an average follow-up of 40.2 weeks. The researchers found that sinus symptoms were improved in 95.2%, unchanged in 3.8%, and worse in 1.0% of patients. Postoperative sinus infections were significantly less frequent and less severe compared to infections before surgery. The results were consistent across all patient categories, including balloon-only patients and revision patients. No adverse events were attributable to balloon sinuplasty. The study was published in the April 2008 issue of Annals of Otology, Rhinology, & Laryngology.

"The results from this study reinforce the outstanding safety record of balloon sinuplasty technology, and underscore its effectiveness in alleviating chronic sinusitis symptoms,” said lead author Howard Levine, M.D., director of the Cleveland Nasal, Sinus, and Sleep Center. "Results were universally excellent across a large population of patients and dozens of different practices.”

Balloon sinuplasty, a technology developed by Acclarent (Menlo Park, CA, USA), is similar in concept to catheters used for cardiac balloon angioplasty. The specially designed devices are threaded into the sinus passageways and gently inflated, widening the passages to promote drainage and resolution of chronic sinusitis symptoms. The technology can be used as a stand-alone system or with standard surgical instrumentation. Recovery times vary, but patients typically return to normal activities within 24 hours of treatment.

Chronic sinusitis is an inflammation of the nasal sinuses afflicting an estimated 37 million people annually in the United States alone. Symptoms include facial pain or pressure, nasal discharge, difficulty breathing through the nose, and fatigue. Although antibiotics and topical steroids can help many people, approximately 500,000 U.S. patients undergo surgery each year to alleviate the symptoms of chronic sinusitis.


Related Links:
Cleveland Nasal, Sinus, and Sleep Center
Acclarent

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.